Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hoth Therapeutics Inc (NQ: HOTH ) 0.7260 +0.0255 (+3.64%) Streaming Delayed Price Updated: 3:51 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Hoth Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > EXCLUSIVE: Hoth Therapeutics Gives Cannabinoid-Based Lupus Candidate Back To Zylö December 08, 2021 Hoth Therapeutics Inc (NASDAQ: HOTH) has agreed to license its cannabinoid therapeutic, HT-005, for lupus patients back to Zylö Therapeutics. What Happened: In August 2019,... Via Benzinga Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics December 07, 2021 Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 01, 2021 Gainers Hoth Therapeutics (NASDAQ:HOTH) s... Via Benzinga EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa November 30, 2021 Hoth Therapeutics Inc (NASDAQ: HOTH) has begun enrollment and dosing for the second cohort in its Phase 1b trial of topical BioLexa to treat mild to moderate atopic... Via Benzinga Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers November 16, 2021 Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced an oncology R&D collaboration on Tuesday. What Happened: New York-based Hoth, a biopharma focusing on new-age therapies for... Via Benzinga The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business August 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 16, 2021 Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8... Via Benzinga Hoth Therapeutics Enters Into Agreements with WuXi STA; Attempts to Get New Cancer Treatment Closer to Clinical Trials November 11, 2021 Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a... Via Benzinga This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria November 09, 2021 Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner... Via Benzinga Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs November 03, 2021 Photo by Roberto Sorin on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga Hoth Therapeutics Says the Possibilities Could Be Endless October 28, 2021 Photo by Hoth Therapeutics The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... Via Benzinga Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans October 12, 2021 NEW YORK, NY /PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Human Research Ethics... Via Benzinga Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications October 06, 2021 Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which revealed the strongest balance... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 08, 2021 Gainers Kadmon Holdings (NASDAQ:KDMN) shares rose 73.39% to $9.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.5... Via Benzinga EXCLUSIVE: Hoth Reports Safety Data From Early-Stage Study Of BioLexa Platform In Eczema September 08, 2021 Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma engaged in the development of therapies for unmet need, releases positive early-stage data for its BioLexa... Via Benzinga The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session September 01, 2021 Gainers INmune Bio (NASDAQ:INMB) shares ... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 18, 2021 Gainers Protagenic Therapeutics (NASDAQ:PTIX... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 11, 2021 Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The... Via Benzinga 22 Stocks Moving in Wednesday's Pre-Market Session August 11, 2021 Gainers CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's After-Market Session August 03, 2021 Gainers Cerus (NASDAQ:CERS) shares incre... Via Benzinga Hoth Therapeutics Starts Preclinical Study For Its Alzheimer's Candidate August 02, 2021 Hoth Therapeutics Inc (NASDAQ: HOTH) has initiated its preclinical study utilizing Hoth's HT-ALZ in an animal model. The study aims to determine the effects of... Via Benzinga Hoth Therapeutics' HT-003 Shows Encouraging Action Against Acne In Animal Model July 13, 2021 Hoth Therapeutics Inc (NASDAQ: HOTH) has announced that its HT-003 group of assets has yielded positive results in an in vivo acne therapeutic model. The model... Via Benzinga Hoth Therapeutics Unveils Preclinical Results of HT-KIT Therapeutic Program June 03, 2021 Hoth Therapeutics Inc (NASDAQ: HOTH) has reported results from a preclinical trial of HT-KIT, a new molecular entity under development to treat mast cell-derived... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session June 02, 2021 Gainers Tilray (NASDAQ:TLRY) shares incre... Via Benzinga The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron May 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.